Landon Foundation-AACR INNOVATOR Award for Research in Personalized Cancer Medicine is designed to accelerate progress in the area of personalized cancer medicine by providing support for physician-scientists who conduct meritorious studies that hold promise for near-patient benefit. The award provides a two-year grant of $100,000 to support direct research expenses, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, and/or research assistants, research/laboratory supplies, and equipment.
Are you planning to submit an NIH grant application? If so, please note that all applications intended for due dates on or after January 25, 2010* require the use of new forms and instructions. Major changes include:
- Restructured forms to align with review criteria
- Significantly shorter page limits
These changes apply to all competing applications, so whether you are submitting a new, renewal, resubmission or revision, you must take action now to ensure a successful submission!
1. Return to the updated funding opportunity announcement or reissued parent announcement to download the new application package and instructions.
– FOAs are in the process of being updated. See timeline for more information.
2. Be sure to choose the correct forms. Applications intended for due dates on or after January 25 require new forms.
– For Electronic SF 424 (R&R): ADOBE FORMS-B
– For Paper PHS 398: Revision date “June 2009”
3. Read the updated FOA and new application instructions carefully
For more details the Enhancing Peer Review Web site which has a page dedicated to the upcoming application changes, as well as a number of additional resources including:
*Applicants eligible for continuous submission who are submitting R01, R21 and R34 AIDS applications should use the old SF 424 (R&R) ADOBE-FORMS-A on or before February 7, 2010 and the new SF 424 (R&R) ADOBE-FORMS-B thereafter. Non-AIDS applications from applicants eligible for continuous submission need to use ADOBE-FORMS-A on or before January 24, and the ADOBE-FORMS-B on or after January 25, 2010.
Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research recognizes outstanding achievement by junior faculty in any discipline of cancer prevention research. The projects must describe novel and innovative research that, if successful, will have strong potential for high impact in the cancer prevention field. The award provides a 2-year grant of $100,000 ($50,000 per year) for direct research expenses; which may include salary and benefits, equipment, and supplies; and for attendance at AACR Meetings for the purpose of participating in scholarly exchange.
The NCMHD Health Disparities Research on Minority and Underserved Populations (R01) seeks innovative research addressing elements that eliminates health disparities. Research focused on disease and/or conditions that disproportionately affect racial/ethnic minorities is a growing field and has been employed lately in understanding dynamics contributing to health disparities. Funding for this FOA will support investigators who propose to conduct health disparities research using its principles to improve health inequities. The research should take into account the characteristics of health systems and health seeking behaviors that propagate disparities. The focus of targeted research population is diverse. It includes ethnic racial minorities, medically underserved and vulnerable populations, and rural and low-income populations. Several approaches could be used when designing programs; specific interventions may include but are not limited to biological, behavioral change strategies, lifestyle factors, environmental, social and structural barriers, economics, institutional and cultural, family influences, delivery system interventions, medical procedures and regimens (including alternative therapy), medical and assistive devices and technologies.
This purpose of the NCMHD DREAM Career Transition Award (K22) is to facilitate the transition of early stage investigators working in health disparities or areas that address health disparity conditions and populations from the mentored stage of career development to the independent stage of investigator-initiated health disparities research. The program will provide an opportunity for investigators to develop solid research skills during the initial period of up to two years of study and research within the environment of the NIH Intramural Research Programs located at the NIH. The award may also include a follow-on period of up to three years of salary and mentored research support at the candidate’s current institution or organization or an academic or research grantee institution of the candidate’s choice. This period of extramural support will facilitate the transition to independence as a researcher in health disparities research.
The Era of Hope Scholar Award supports individuals who have high potential for innovation in breast cancer research early in their careers. Nominees for this award should be exceptionally talented, early-career scientists who have demonstrated that they are the “best and brightest” in their field(s) through extraordinary creativity, vision, and productivity. They also should exhibit strong potential for leadership in the breast cancer research community and be able to articulate a vision for the eradication of breast cancer. Experience in breast cancer research is not required; however, the application should focus on breast cancer research, and the PI must commit at least 50% of his/her full-time professional effort during the award period to breast cancer research. Principal Investigators (PIs) must be independent, non-mentored investigators within 6 years of their last mentored position.
Postdoctoral Fellowship Awards support exceptionally talented recent medical or other doctoral graduates in their pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. The postdoctoral trainee is considered the Principal Investigator (PI) and, as such, should write the project narrative with appropriate direction from the mentor. While the PI is not required to have previous experience in breast cancer research, this application must focus on breast cancer research. Applications must provide evidence of the PI’s potential for success in becoming an independent breast cancer researcher based on his/her qualifications, characteristics, achievements, and letters of recommendations. The mentor (or co-mentor, if applicable) must possess the appropriate expertise and experience in breast cancer, to include peer reviewed breast cancer funding and publications, and clearly demonstrate a commitment to guiding the PI’s research and training. As of the application submission deadline, the PI must have been in the laboratory in which this research is to be performed for no more than 2 years, and he/she must have a total of less than 4 years of postdoctoral research experience (excluding clinical residency or fellowship training).
DEADLINES for FY09 BCRP Era of Hope Scholar Awards and Postdoctoral Fellowship Awards:
- Pre-Application through http://cdmrp.org/ required and due: November 18, 2009, 5:00 p.m. Eastern Time.
- Confidential Letters of Recommendation through the http://cdmrp.org , are required and due: December 2, 2009, 5:00 p.m. Eastern Time.
- Application is to be submitted through http://www.grants.gov/ due December 2, 2009, 11:59 p.m. Eastern Time.